SOLASTA VENTURES, INC
SOLASTA VENTURES, INC is a Seed, Series A and Series B fund in the US and global writing $1M–$10M checks into life-sciences, biotechnology, therapeutics and medical-devices.
- Stages
- Seed, Series A, Series B
- Sectors
- life-sciences, biotechnology, therapeutics, medical-devices
- Check size
- $1M–$10M
- Invests in
- US-wide, global
- Actively investing
- Yes
- Founded
- 2019
- Website
- solasta-ventures.com
Thesis
Solasta Ventures, Inc. is a venture capital firm established in 2019 and headquartered in Boston, Massachusetts. As a subsidiary of South Korea's Aju IB Investment, Solasta focuses on the life sciences sector, particularly therapeutics and technologies that can advance patient care. They actively invest in early-stage startups, preferring Seed, Series A, and Series B rounds, and seek out strong management teams. Their strategy emphasizes partnerships with global pharmaceutical companies and leveraging their South Korean network for cross-border synergies. The firm typically invests between $1 million and $10 million per deal. While specific AUM is not disclosed, they manage the 'Aju-Solasta Life Science 4.0 Fund'. Their geographic focus is global, with a strong emphasis on the U.S. market.
Common questions
Does SOLASTA VENTURES, INC invest at the Seed stage?
Yes. SOLASTA VENTURES, INC lists Seed, Series A and Series B among the stages it invests in.
What check size does SOLASTA VENTURES, INC write?
SOLASTA VENTURES, INC writes $1M–$10M checks.
Where does SOLASTA VENTURES, INC invest?
SOLASTA VENTURES, INC invests in the US and global.